Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L Macdonald

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Journal of Medicinal Chemistry|February 15, 2001
Design, synthesis, and evaluation of novel A2A adenosine receptor agonistsJ M Rieger, M L Brown, G W Sullivan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Inhibition of topoisomerases by fredericamycin AM D Latham, C K King, P Gorycki, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 19, 2001
Selective A(2A) adenosine receptor activation reduces skin pressure ulcer formation and inflammationS M Peirce, T C Skalak, J M Rieger, et al.
British Journal of Pharmacology|February 28, 2001
Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonistsG W Sullivan, J M Rieger, W M Scheld, et al.
Experimental Eye Research|May 1, 1997
Mechanisms of adrenergic agonist induced allergy bioactivation and antigen formationC D Thompson, T L Macdonald, M E Garst, et al.
The Journal of Biological Chemistry|August 24, 2001
Accelerated s-nitrosothiol breakdown by amyotrophic lateral sclerosis mutant copper,zinc-superoxide dismutaseM A Johnson, T L Macdonald, J B Mannick, et al.
Journal of Medicinal Chemistry|November 26, 1997
Synthesis and structure-activity profiles of A-homoestranes, the estratroponesT A Miller, A L Bulman, C D Thompson, et al.
Chemical Research in Toxicology|May 23, 2001
Role of glutathione S-transferases A1-1, M1-1, and P1-1 in the detoxification of 2-phenylpropenal, a reactive felbamate metaboliteC M Dieckhaus, S G Roller, W L Santos, et al.
Journal of Medicinal Chemistry|March 26, 1999
Structure--activity relationships of lysophosphatidic acid: conformationally restricted backbone mimeticsD W Hopper, S P Ragan, S B Hooks, et al.
Bioorganic & Medicinal Chemistry|November 14, 1997
Structure-activity relationship for DNA topoisomerase II-induced DNA cleavage by azatoxin analoguesJ S Madalengoitia, J J Tepe, K A Werbovetz, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|February 15, 2001
Design, synthesis, and evaluation of novel A2A adenosine receptor agonistsJ M Rieger, M L Brown, G W Sullivan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Inhibition of topoisomerases by fredericamycin AM D Latham, C K King, P Gorycki, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 19, 2001
Selective A(2A) adenosine receptor activation reduces skin pressure ulcer formation and inflammationS M Peirce, T C Skalak, J M Rieger, et al.
British Journal of Pharmacology|February 28, 2001
Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonistsG W Sullivan, J M Rieger, W M Scheld, et al.
Experimental Eye Research|May 1, 1997
Mechanisms of adrenergic agonist induced allergy bioactivation and antigen formationC D Thompson, T L Macdonald, M E Garst, et al.
The Journal of Biological Chemistry|August 24, 2001
Accelerated s-nitrosothiol breakdown by amyotrophic lateral sclerosis mutant copper,zinc-superoxide dismutaseM A Johnson, T L Macdonald, J B Mannick, et al.
Journal of Medicinal Chemistry|November 26, 1997
Synthesis and structure-activity profiles of A-homoestranes, the estratroponesT A Miller, A L Bulman, C D Thompson, et al.
Chemical Research in Toxicology|May 23, 2001
Role of glutathione S-transferases A1-1, M1-1, and P1-1 in the detoxification of 2-phenylpropenal, a reactive felbamate metaboliteC M Dieckhaus, S G Roller, W L Santos, et al.
Journal of Medicinal Chemistry|March 26, 1999
Structure--activity relationships of lysophosphatidic acid: conformationally restricted backbone mimeticsD W Hopper, S P Ragan, S B Hooks, et al.
Bioorganic & Medicinal Chemistry|November 14, 1997
Structure-activity relationship for DNA topoisomerase II-induced DNA cleavage by azatoxin analoguesJ S Madalengoitia, J J Tepe, K A Werbovetz, et al.
Pageof 7